Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quantum Biopharma (QNTM) Profit After Tax (2019 - 2025)

Quantum Biopharma's Profit After Tax history spans 7 years, with the latest figure at -$2.3 million for Q4 2025.

  • On a quarterly basis, Profit After Tax fell 10.01% to -$2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$20.8 million, a 752.46% decrease, with the full-year FY2025 number at -$27.0 million, down 80.73% from a year prior.
  • Profit After Tax hit -$2.3 million in Q4 2025 for Quantum Biopharma, up from -$4.8 million in the prior quarter.
  • Over the last five years, Profit After Tax for QNTM hit a ceiling of $49.9 million in Q3 2021 and a floor of -$61.7 million in Q4 2021.
  • Historically, Profit After Tax has averaged -$4.9 million across 5 years, with a median of -$2.1 million in 2024.
  • The widest YoY moves for Profit After Tax: up 468.97% in 2021, down 350.51% in 2021.
  • Tracing QNTM's Profit After Tax over 5 years: stood at -$61.7 million in 2021, then increased by 23.42% to -$47.3 million in 2022, then grew by 26.34% to -$34.8 million in 2023, then surged by 93.99% to -$2.1 million in 2024, then decreased by 10.01% to -$2.3 million in 2025.
  • Business Quant data shows Profit After Tax for QNTM at -$2.3 million in Q4 2025, -$4.8 million in Q3 2025, and -$5.0 million in Q2 2025.